Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
Region: All Regions > Europe
Category: All Categories > Life Sciences > Pharmaceuticals > Country Overviews
(260 reports matching your criteria)
 
1  2  3    5    7  8  9  10  
Sweden Pharmaceuticals and Healthcare Report Q3 2012
5/8/2012 | published by: Business Monitor International
... and the subsequent entry of copy products, coupled with the government’s focus on cost containment through measures that will encourage the consumption of cheaper generic medicines. Nevertheless, population ageing as well as continued growth will ...  |  read more...
$1,175.00
Pharmaceuticals – Czech Republic – a snapshot (2011)
4/19/2012 | published by: Mintel - Snapshots
... as hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Czech Republic is given in %, CZK and USD with a minimum of five years' ...  |  read more...
$600.00
Pharmaceuticals – Slovak Republic – a snapshot (2011)
4/10/2012 | published by: Mintel - Snapshots
... as hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Slovak Republic is given in %, EUR and USD with a minimum of five years' ...  |  read more...
$600.00
Pharmaceuticals – UK – a snapshot (2011)
4/5/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in UK is given in %, GBP and USD with a minimum of five years' historical data. ...  |  read more...
$600.00
Pharmaceuticals – Poland – a snapshot (2011)
3/23/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Poland is given in PLN with a minimum of five years' historical data. Market Forecast is ...  |  read more...
$600.00
Switzerland Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
... a result of the increased prevalence of chronic disease with age, thereforeconsuming a disproportionately large share of healthcare services. Such robust demand for services overthe coming years means the government will need to adapt strategies ...  |  read more...
$1,175.00
Romania Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
... in January – but were nevertheless expected to bereconsidered – are now less likely progress. The new claw-back tax, which has been in effect sinceOctober 2011 and was modified in November, is expected to remain ...  |  read more...
$1,175.00
Moldova Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
... the pharmaceutical market will achieve elevated growth over thenext five years and this view has been reinforced by the latest available trade data. However, the countryeconomic growth path is dependent on the stability of the ...  |  read more...
$1,175.00
Portugal Pharmaceuticals and Healthcare Report Q2 2012
3/20/2012 | published by: Business Monitor International
... branded and generic drugs throughout 2010 and 2011, more austerity measures will be implemented in2012. Since the end of 2011, changes to the reference pricing system have been enforced, as has a law that obligesany ...  |  read more...
$1,175.00
Bulgaria Pharmaceuticals and Healthcare Report Q2 2012
3/6/2012 | published by: Business Monitor International
... outlook for the year, supported by the fact that despite contractions in the wider economy in 2009 and weak growth in 2010, the drug market remained resistant to this weakness. Out-of-pocket expenditure will continue to ...  |  read more...
$1,175.00
France Pharmaceuticals and Healthcare Report Q2 2012
3/6/2012 | published by: Business Monitor International
... and the potential need for state-led capital injections in the domestic banking sector. Given France’s high public debt-to-GDP ratio, this raises the prospect that the country’s sovereign creditworthiness could be called into serious doubt, which ...  |  read more...
$1,175.00
Poland Pharmaceuticals and Healthcare Report Q2 2012
3/6/2012 | published by: Business Monitor International
... lead to an annual market contraction, though we warn growth will be negligible. Small amendments to the act pushed through in January 2012 following doctors’ and pharmacists’ protests are mainly cosmetic, with the main changes ...  |  read more...
$1,175.00
Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform Plans Forecast to Slow Growth Rates
2/29/2012 | published by: GBI Research
... Growth Rates” provides in-depth analysis of trends, issues and challenges in the pharmaceutical market in the Czech Republic. The report analyzes overall pharmaceutical and outsourcing market structure in the Czech Republic. The report provides competitive ...  |  read more...
$3,500.00
Pharmaceuticals – Sweden – a snapshot (2011)
2/29/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Sweden is given in SEK with a minimum of five years' historical data. Market Forecast is ...  |  read more...
$600.00
Switzerland Pharmaceuticals and Healthcare Report Q1 2012
2/28/2012 | published by: Business Monitor International
... sector. Prescription drug spending accounted for 76% of total drug spending in 2010 and public expenditure on health accounted for 58% of total spending on healthcare. Headline Expenditure Projections Pharmaceuticals: CHF5.88bn (US$5.64bn) in 2010 to ...  |  read more...
$1,175.00
Estonia Pharmaceuticals and Healthcare Report Q2 2012
2/28/2012 | published by: Business Monitor International
... 5.07% in local currency terms through to 2016, with the following five years likely to have similar annual growth rates. Nevertheless, Estonia’s proximity to Western Europe will ensure the market continues to be supplied by ...  |  read more...
$1,175.00
Pharmaceuticals – France – a snapshot (2011)
2/27/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in France is given in EUR with a minimum of five years' historical data. Market Forecast is ...  |  read more...
$600.00
The Pharmaceutical Market: Slovakia (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
$1,085.00
The Pharmaceutical Market: Ireland (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
$1,085.00
The Pharmaceutical Market: France (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
$1,085.00
The Pharmaceutical Market: Slovenia (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
$1,085.00
The Pharmaceutical Market: UK (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
$1,085.00
The Pharmaceutical Market: Czech Republic (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
$1,085.00
The Outlook for Pharmaceuticals in Western Europe (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... market. Growth, however, will be tempered somewhat by the effects of the global economic recession in the short term. The leading markets are projected to average a CAGR of 2.1% in US dollar terms up ...  |  read more...
$3,630.00
The Pharmaceutical Market: Bulgaria (pdf/xls)
2/17/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  read more...
$1,085.00
1  2  3    5    7  8  9  10